N/A N=22 Randomized Triple-blind Treatment

Clinical Effects of Exercise Program Added to Pulmonary Rehabilitation in Patients With Cystic Fibrosis

Cystic Fibrosis

Bottom Line

View on ClinicalTrials.gov: NCT03295201 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2018

Primary outcome: Primary: Exercise Tolerance — 817; 792.22 meters

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Active cycle of breathing techniques (ACBT) (Other); Postural Exercise (Other)
Age: Pediatric · 6+ yrs
Sex: All
Sponsor: Marmara University
Primary completion: Oct 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Exercise Tolerance	1251; 1161.11	—
PRIMARY Exercise Tolerance	1251; 1161.11	—
PRIMARY Exercise Tolerance	1251; 1161.11	—
PRIMARY Exercise Tolerance	1251; 1161.11	—
SECONDARY Quality of Life	89.7; 95.55	—
SECONDARY Quality of Life	89.7; 95.55	—
SECONDARY Quality of Life	89.7; 95.55	—
SECONDARY Quality of Life	89.7; 95.55	—
SECONDARY Postural Stability	1.15; 0.92	—
SECONDARY Postural Stability	1.15; 0.92	—
SECONDARY Postural Stability	1.15; 0.92	—
SECONDARY Postural Stability	1.15; 0.92	—
SECONDARY Pulmonary Function	87.7; 90	—
SECONDARY Pulmonary Function	87.7; 90	—
SECONDARY Pulmonary Function	87.7; 90	—
SECONDARY Pulmonary Function	87.7; 90	—
SECONDARY Spinal Deformity- The Cobb Angle (Researcher 1)	3.5; 5.25	—
SECONDARY Spinal Deformity- The Cobb Angle (Researcher 2)	3.88; 5.5	—
SECONDARY Spinal Deformity- The Cobb Angle (Researcher 1)	3.5; 5.25	—
SECONDARY Spinal Deformity- The Cobb Angle (Researcher 2)	3.88; 5.5	—
SECONDARY Spinal Deformity- The Modified Cobb Angle (Researcher 1)	35.5; 32.33	—
SECONDARY Spinal Deformity- The Modified Cobb Angle (Researcher 2)	35; 32.4	—
SECONDARY Spinal Deformity- The Modified Cobb Angle (Researcher 1)	35.5; 32.33	—
SECONDARY Spinal Deformity- The Modified Cobb Angle (Researcher 2)	35; 32.4	—

Summary

The aim of this study is to investigate the effects of postural exercise program added to pulmonary rehabilitation program on quality of life, exercise tolerance and postural stability in children with Cystic Fibrosis.

Eligibility Criteria

Inclusion Criteria

Be diagnosed with KF
Be able to understand commands

Exclusion Criteria

FEV1 below than %30
Cor pulmonale
Advanced gastroesophageal reflux
Current hospital admission due to lung infection
Be diagnosed with neuromuscular disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03295201). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.